Clinical Trials on Endometrioid Carcinoma Ovary in Canada

Total 1691 results

Lawson Health Research Institute
Champions Oncology

Completed

TumorGraft- Guided Therapy for Improved Outcomes in Head and Neck Squamous Cell Cancer- A Feasibility Study (Xenograft)

Head and Neck Squamous Cell Carcinoma

Canada
Meridian Bioscience, Inc.
Medical University of South Carolina; Northwestern University; Hadassah Medical... and other collaborators

Terminated

Detection of Hepatocellular Carcinoma (HCC) With Octanoate Breath ID Test Compared to MRI (OBT for HCC)

Hepatocellular Carcinoma (HCC) | Chronic Liver Disease

Canada
University of Alberta
Alberta Health services

Completed

2B or Not 2B? Shoulder Function After Level 2B Neck Dissection: A Randomized Controlled Study (2BN2B)

Head and Neck Squamous Cell Carcinoma

Canada
University Health Network, Toronto

Enrolling by invitation

Blood Salvage in Orthotopic Liver Transplantation With HCC (SOLT)

Hepatocellular Carcinoma | Surgery

Canada
Ottawa Hospital Research Institute

Unknown

A Feasibility Study for Women Receiving Anthracycline Chemotherapy With or Without Radiation for HER2-neu Positive Invasive Ductal Carcinoma (OTT14-01)

Breast Cancer

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Completed

Hypofractionated Radiotherapy for Limited Stage Small Cell Lung Cancer

Small Cell Carcinoma | Lung Neoplasm

Canada
Dr. Te Vuong
YM BioSciences

Terminated

Nimotuzumab With Radiotherapy in the Treatment of Anal Canal Cancers

Squamous Cell Carcinoma of Anal Canal

Canada
Lawson Health Research Institute

Recruiting

Low-Dose Weekly vs High-Dose Cisplatin (RADIO)

Locally Advanced Head and Neck Squamous Cell Carcinoma

Canada
Centre hospitalier de l'Université de Montréal...
Canadian Institutes of Health Research (CIHR); Centre de Recherche du Centre...

Not yet recruiting

Early Detection of Liver Cancer by QUS (QUS in HCC)

Hepatocellular Carcinoma | Liver Cancer

Canada
London Health Sciences Centre
Pacific Edge Limited

Unknown

The Cxbladder Rule-out of Recurrent Urothelial Carcinoma

Bladder Cancer

Canada
University Health Network, Toronto

Active, not recruiting

Study of Pembrolizumab and Radiotherapy in Liver Cancer

Hepatocellular Carcinoma

Canada
University Health Network, Toronto

Completed

Sorafenib-RT in Treating Hepatocellular Carcinoma (SHEP)

Hepatocellular Carcinoma

Canada
University Health Network, Toronto

Completed

Pharmacological Manipulation of Intrahepatic Arterial Blood Flow in HCC

Hepatocellular Carcinoma

Canada
University of Manitoba

Withdrawn

Treatment of Non-Metastatic Hepatocellular Carcinoma in Humans by Increasing Gabaergic Activity: A Pilot Study

Hepatocellular Carcinoma

Canada
Pfizer
Analysis Group; IMDC group

Completed

Clinical Outcomes For Patients With Metastatic Renal Cell Carcinoma (mRCC) Who Received Sunitinib After 1st Line Immune-oncology (IO) Treatments

Metastatic Renal Cell Carcinoma (mRCC)

Canada
University Health Network, Toronto

Recruiting

HN-BIO: A Study of Head and Neck MRI and Tumor Microenvironment Biomarkers

Squamous Cell Carcinoma of Head and Neck

Canada
British Columbia Cancer Agency

Recruiting

DOTATOC PET/CT for Imaging NET Patients

Pituitary Adenoma | Neuroendocrine Tumors | Medulloblastoma | Small-cell Lung Cancer | Neuroblastoma | Meningioma | Merkel Cell Carcinoma | Pheochromocytoma | Paraganglioma | Gastrinoma | Glucagonoma | Insulinoma | Vipoma | Carcinoid | Ganglioneuroma | Medullary Carcinoma

Canada
Unity Health Toronto

Completed

Virtual Mindfulness for the Management of Endometriosis Pelvic Pain.

Chronic Pain | Endometriosis

Canada
Pfizer
International Metastatic Renal Cell Carcinoma Database Consortium (IMDC); Analysis...

Completed

Clinical Outcomes for Patients With Renal Cell Carcinoma Who Received First-Line Sunitinib

Metastatic Renal Cell Carcinoma

Canada
AHS Cancer Control Alberta
Cross Cancer Institute; Tom Baker Cancer Centre

Recruiting

p16+ Oropharyngeal Cancer Radiation Optimization Trial Reducing Elective Treatment Volumes (PROTEcT) (PROTEcT)

Squamous Cell Carcinoma of the Oropharynx

Canada
Lawson Health Research Institute

Active, not recruiting

An Open Label Registry Study of Lutetium-177 (DOTA0, TYR3) Octreotate (Lu-DOTA-TATE) Treatment in Patients With Somatostatin Receptor Positive Tumours

Neuroendocrine Carcinoma

Canada
University of British Columbia

Completed

TACE Study-Liver Embolization Perfusion (VGH Radiology LIU) (TACE)

Unresectable Hepatocellular Carcinoma | Undergoing Chemoembolization and Radioembolization

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Completed

Cone Beam CT Scanning in Lung and Bladder Cancer.

Bladder Carcinoma | Small Cell Carcinoma | Lung Neoplasm

Canada
McGill University Health Centre/Research Institute...
Pfizer

Completed

PET Scan as a Screening Tool for Liver Transplant in Patients With Hepatocellular Carcinoma (HCC)

Hepatocellular Carcinoma

Canada
University Health Network, Toronto
Princess Margaret Hospital, Canada

Completed

Hardwins - Squamous Cell Carcinoma Head & Neck (Surgery/RT)

Carcinoma, Squamous Cell

Canada
University Health Network, Toronto

Recruiting

Evaluation of Gd-EOB-DTPA MRI for Detection and Characterization of Liver Nodules in Cirrhotic Patients Undergoing Liver Transplantation and Potential Impact on Transplant Eligibility

Hepatocellular Carcinoma

Canada
University Health Network, Toronto
Princess Margaret Hospital, Canada

Completed

Study of Circulating Tumor DNA (ctDNA) Kinetics in Immuno-oncology (IO-KIN)

Head and Neck Cancer | Metastatic Cancer | Advanced Cancer | HNSCC | Squamous Cell Carcinoma

Canada
Ottawa Hospital Research Institute
Ozmosis Research Inc.

Completed

Phase I Study of a Statin + Erlotinib for Advanced Solid Malignancies With Focus on Squamous Cell Carcinomas and NSCLC

Non-Small Cell Lung Cancer | Squamous Cell Carcinoma

Canada
Lawson Health Research Institute
Sunnybrook Health Sciences Centre; Weill Medical College of Cornell University and other collaborators

Active, not recruiting

Stereotactic Image-Guided Neoadjuvant Ablative Radiation Then Lumpectomy (SIGNAL 2)

Early Stage Breast Carcinoma

Canada
Sunnybrook Health Sciences Centre
Merck KGaA, Darmstadt, Germany

Completed

Avelumab in G3 NEC (NET-001)

Neuroendocrine Carcinoma

Canada
University Health Network, Toronto

Withdrawn

Maintenance Treatment With Bevacizumab and Atezolizumab for Ovarian Cancer

Fallopian Tube Cancer | Primary Peritoneal Cancer | Ovarian Endometrioid Tumor | TP53 Mutation

Canada
Laval University
Canadian Diabetes Association; Diabetes Québec; Institute of Nutraceuticals and...

Completed

Assessment of Cod Protein as an Insulin-sensitizing Agent in Women With Polycystic Ovary Syndrome. (PCOS)

Polycystic Ovarian Syndrome | Insulin Sensitivity

Canada
British Columbia Cancer Agency

Unknown

Hepatocellular Carcinoma Using Stereotactic Body Radiotherapy

Hepatocellular Carcinoma

Canada
University of British Columbia

Completed

Clinical Study Examining the Safety and Efficacy of Doxorubicin Drug Eluting Microspheres Transarterial Embolization in the Setting of Hepatocellular Carcinoma (HCC)

Hepatocellular Carcinoma

Canada
University Health Network, Toronto
AstraZeneca

Withdrawn

A Multi-Cancer, Multi-State, Platform Study of Durvalumab (MEDI4736) and Oleclumab (MEDI9447) in Pancreatic Adenocarcinoma, Non-Small Cell Lung Cancer and Squamous Cell Carcinoma of the Head and Neck to Correlate Clinical, Molecular and Immunologic Parameters With DNA Methylation (DOME)

Squamous Cell Carcinoma of Head and Neck | Non-small Cell Lung Cancer | Pancreatic Ductal Adenocarcinoma

Canada
National Cancer Institute (NCI)

Withdrawn

Testing Anti-Cancer Drugs Erdafitinib With or Without Atezolizumab in Patients With Localized Bladder Cancer Not Able to Receive Cisplatin Chemotherapy, NERA Trial

Urothelial Carcinoma | Renal Pelvis and Ureter Urothelial Carcinoma | Bladder Carcinoma | Stage III Bladder Cancer AJCC v8 | Stage IVA Bladder Cancer AJCC v8 | Bladder Urothelial Carcinoma | Muscle Invasive Bladder Carcinoma | Stage II Bladder Cancer AJCC v8

Canada
Sunnybrook Health Sciences Centre

Completed

Analysis of Patterns of Recurrence in Head and Neck Cancer Using Clinicopathomic Markers

Squamous Cell Carcinoma of Head and Neck | Head and Neck Neoplasm

Canada
Centre hospitalier de l'Université de Montréal...
AstraZeneca

Active, not recruiting

Immunotherapy and SBRT for Metastatic Head and Neck Carcinomas

Head and Neck Squamous Cell Carcinoma | Metastatic Squamous Cell Carcinoma

Canada
British Columbia Cancer Agency

Completed

Feasibility of VMAT and CBCT for Head and Neck Carcinomas

Head and Neck Carcinoma

Canada
National Cancer Institute (NCI)

Completed

Sunitinib Malate in Treating Patients With Uterine Cervical Cancer That is Stage IVB, Recurrent, or Cannot Be Removed By Surgery

Cervical Adenocarcinoma | Cervical Squamous Cell Carcinoma | Recurrent Cervical Cancer | Stage IVB Cervical Cancer | Cervical Adenosquamous Cell Carcinoma

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Completed

Study of Radiation Dose Intensity Concurrent With Chemotherapy For Limited Stage Small Cell Lung Cancer

Carcinoma, Small Cell

Canada
McMaster University
Canadian Breast Cancer Foundation

Completed

Trial Comparing Radioactive Seed Localization to Standard Procedure for Non-palpable Breast Cancers

Breast Cancer Invasive Nos | Stage 0 Breast Carcinoma

Canada
National Cancer Institute (NCI)

Completed

Temsirolimus in Treating Patients With Cervical Cancer That Is Recurrent, Locally Advanced, Metastatic, or Cannot Be Removed By Surgery

Cervical Adenocarcinoma | Cervical Adenosquamous Carcinoma | Cervical Squamous Cell Carcinoma | Recurrent Cervical Carcinoma | Stage IVA Cervical Cancer | Stage IVB Cervical Cancer | Stage IIIA Cervical Cancer | Stage IIIB Cervical Cancer

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Completed

MVCT Imaging Pilot Study Using Helical Tomotherapy

Cancer, Carcinoma

Canada
Western University

Recruiting

[18F] PSMA-1007 PET/CT in Metastatic Clear Cell Renal Cell Carcinoma

Metastatic Clear Cell Renal Cell Carcinoma

Canada
NCIC Clinical Trials Group
Roche Pharma AG

Completed

Adjuvant Erlotinib After Completing Chemoradiotherapy in Locally Advanced Squamous Cell Carcinoma of the Head and Neck

Head and Neck Cancer

Canada
AHS Cancer Control Alberta
University of Calgary; Calgary Health Region

Completed

PET-CT for Squamous Cell Carcinoma (SCC) of the Neck Nodes Unknown Primary Malignancy

Squamous Cell Cancer

Canada
National Cancer Institute (NCI)

Completed

Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 and Temsirolimus in Treating Patients With Advanced Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific | Stage III Renal Cell Cancer | Recurrent Endometrial Carcinoma | Stage IV Renal Cell Cancer | Recurrent Renal Cell Cancer | Stage IV Endometrial Carcinoma | Stage III Endometrial Carcinoma | Endometrial Papillary Serous Carcinoma

Canada
Ontario Clinical Oncology Group (OCOG)
Ontario Ministry of Health and Long Term Care

Completed

Positron Emission Tomography (PET) Imaging in Stage III Non-small Cell Lung Cancer (PET START Trial)

Non-Small-Cell Lung Carcinoma

Canada
Association of Dermatological Prevention, Germany
University of Alberta; University of Calgary

Unknown

Skin Cancer Screening Education Study (SCSES)

Melanoma | Basal Cell Carcinoma | Squamous Cell Carcinoma | Skin Tumors

Canada

Clinical Trials on Endometrioid Carcinoma Ovary in Canada

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Papua New Guinea

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations